| Dr Jeffrey Weber, MD | |
|
12902 Usf Magnolia Dr, Mdc 44, Tampa, FL 33612-9416 | |
| (813) 745-1536 | |
| (813) 974-0483 |
| Full Name | Dr Jeffrey Weber |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 49 Years |
| Location | 12902 Usf Magnolia Dr, Tampa, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053348706 | NPI | - | NPPES |
| 278581100 | Medicaid | FL | |
| 90621 | Other | FL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | G47964 (California) | Secondary |
| 207RX0202X | Internal Medicine - Medical Oncology | ME99194 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
Although some reports have suggested a link between the use of oral bisphosphonates (drugs that prevent the loss of bone mass) and esophageal cancer, analysis of medical data from more than 80,000 patients in the United Kingdom found that use of these drugs was not significantly associated with new cases of esophageal or gastric cancer, according to a study in the August 11 issue of JAMA.
Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, with only surgery shown to provide a cure. However, the vast majority of patients have tumors that cannot be removed surgically or their cancer is too advanced or spread too far to be treatable.
University of Leicester researchers discover sweat can cause corrosion of protective qualities of door knobs and taps within an hour of contact
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
e year the state of Florida eliminates its popular MediPass program, which gives more than half a million Medicaid recipients, mostly aged and disabled Floridians, an alternative to HMOs. Hints of its demise showed up in the governor's budget and letters from a powerful lawmaker.
› Verified 2 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Although some reports have suggested a link between the use of oral bisphosphonates (drugs that prevent the loss of bone mass) and esophageal cancer, analysis of medical data from more than 80,000 patients in the United Kingdom found that use of these drugs was not significantly associated with new cases of esophageal or gastric cancer, according to a study in the August 11 issue of JAMA.
Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, with only surgery shown to provide a cure. However, the vast majority of patients have tumors that cannot be removed surgically or their cancer is too advanced or spread too far to be treatable.
University of Leicester researchers discover sweat can cause corrosion of protective qualities of door knobs and taps within an hour of contact
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
e year the state of Florida eliminates its popular MediPass program, which gives more than half a million Medicaid recipients, mostly aged and disabled Floridians, an alternative to HMOs. Hints of its demise showed up in the governor's budget and letters from a powerful lawmaker.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Weber, MD Po Box 917770, Orlando, FL 32891-7770 Ph: () - | Dr Jeffrey Weber, MD 12902 Usf Magnolia Dr, Mdc 44, Tampa, FL 33612-9416 Ph: (813) 745-1536 |
News Archive
Although some reports have suggested a link between the use of oral bisphosphonates (drugs that prevent the loss of bone mass) and esophageal cancer, analysis of medical data from more than 80,000 patients in the United Kingdom found that use of these drugs was not significantly associated with new cases of esophageal or gastric cancer, according to a study in the August 11 issue of JAMA.
Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, with only surgery shown to provide a cure. However, the vast majority of patients have tumors that cannot be removed surgically or their cancer is too advanced or spread too far to be treatable.
University of Leicester researchers discover sweat can cause corrosion of protective qualities of door knobs and taps within an hour of contact
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
e year the state of Florida eliminates its popular MediPass program, which gives more than half a million Medicaid recipients, mostly aged and disabled Floridians, an alternative to HMOs. Hints of its demise showed up in the governor's budget and letters from a powerful lawmaker.
› Verified 2 days ago
Chhavi Gupta, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 508 S Habana Ave., Suite 270, Tampa, FL 33609 Phone: 813-388-1732 Fax: 813-864-9292 | |
Dr. Luis Leon Alvarado, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Blvd, Va 111, Tampa, FL 33612 Phone: 813-972-2000 Fax: 813-631-3423 | |
Dr. Nirmal Shyam Sharma, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Tampa General Cir Fl Circle6, Tampa, FL 33606 Phone: 813-974-2201 | |
Aniqa Shahrier, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3003 W Dr Martin Luther King Jr Blvd Fl 3, Tampa, FL 33607 Phone: 877-537-4787 | |
Sriprintha Navarathinarajah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5130 Sunforest Dr Ste 300, Tampa, FL 33634 Phone: 727-824-0780 Fax: 813-514-8891 | |
Dr. Olga Kaliebe, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2919 W Swann Ave, Tampa, FL 33609 Phone: 813-392-1900 Fax: 813-392-1901 | |
William Dinwoodie, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 12902 Usf Magnolia Dr, Mdc 44, Tampa, FL 33612 Phone: 813-745-3980 Fax: 813-745-7229 |